Shared posts

27 Feb 16:21

Perspectives: Giving credit where it is due

by Cassidy R. Sugimoto,Indiana University, Bloomington and, Vincent Larivière, University of Montreal
Tracking contributorship rather than authorship reveals unconscious gender and status disparities in publishing
20 Oct 13:17

On-Demand Complex Peptide Synthesis: An Aspirational (and Elusive?) Goal for Peptide Synthesis

by Kenneth E. Schwieter and Jeffrey N. Johnston

TOC Graphic

Journal of the American Chemical Society
DOI: 10.1021/jacs.6b08663
19 Oct 17:12

Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth

by Sounik Saha, Xunhao Xiong, Prabir K. Chakraborty, Khader Shameer, Rochelle R. Arvizo, Rachel A. Kudgus, Shailendra Kumar Dhar Dwivedi, Md. Nazir Hossen, Elizabeth M. Gillies, J. David Robertson, Joel T. Dudley, Raul A. Urrutia, Russell G. Postier, Resham Bhattacharya and Priyabrata Mukherjee

TOC Graphic

ACS Nano
DOI: 10.1021/acsnano.6b02231
18 Oct 20:37

Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery

by Giulio F. Paciotti, Jielu Zhao, Shugeng Cao, Peggy J. Brodie, Lawrence Tamarkin, Marja Huhta, Lonnie D. Myer, Jay Friedman and David G. I. Kingston

TOC Graphic

Bioconjugate Chemistry
DOI: 10.1021/acs.bioconjchem.6b00405
18 Oct 17:25

Modulating Drug Release Rate from Partially Silica-Coated Bicellar Nanodisc by Incorporating PEGylated Phospholipid

by Li Lin, Xiaoyou Wang, Xiaoda Li, Yongbo Yang, Xiuli Yue, Qiang Zhang and Zhifei Dai

TOC Graphic

Bioconjugate Chemistry
DOI: 10.1021/acs.bioconjchem.6b00508
18 Oct 13:05

A New Design Strategy and Diagnostic to Tailor the DNA-Binding Mechanism of Small Organic Molecules and Drugs

by Phi Doan, Demar R. G. Pitter, Andrea Kocher, James N. Wilson and Theodore Goodson

TOC Graphic

ACS Chemical Biology
DOI: 10.1021/acschembio.6b00448
12 Oct 13:14

Roger Y. Tsien (1952–2016)

by Stephen R. Adams
Thumbnail image of graphical abstract

Roger Y. Tsien, professor at the University of California, San Diego and Howard Hughes Medical Institute Investigator, passed away on August 24, 2016. Tsien shared the 2008 Nobel Prize in Chemistry for his work on the discovery and development of the green fluorescent protein, and developed a whole series of colored fluorescent proteins, as well as widely used small-molecule probes for Ca2+ ions.

07 Oct 12:40

Improving the Intracellular Drug Concentration in Lung Cancer Treatment through the Codelivery of Doxorubicin and miR-519c Mediated by Porous PLGA Microparticle

by Di Wu, Chenhui Wang, Jiebing Yang, Hao Wang, Haobo Han, Aijun Zhang, Yan Yang and Quanshun Li

TOC Graphic

Molecular Pharmaceutics
DOI: 10.1021/acs.molpharmaceut.6b00702
06 Oct 01:50

Approaches to Study Phosphatases

by Sara Fahs, Pablo Lujan and Maja Köhn

TOC Graphic

ACS Chemical Biology
DOI: 10.1021/acschembio.6b00570
05 Oct 20:03

Medicine Nobel for research on how cells 'eat themselves'

by Richard Van Noorden

Medicine Nobel for research on how cells 'eat themselves'

Nature 538, 7623 (2016). http://www.nature.com/doifinder/10.1038/nature.2016.20721

Authors: Richard Van Noorden & Heidi Ledford

Japanese biologist Yoshinori Ohsumi recognized for work on autophagy.

04 Oct 16:06

9-Silafluorenyl Dichlorides as Chemically Ligating Coupling Agents and Their Application in Peptide Synthesis

by Samuel J. Aspin, Sylvain Taillemaud, Patrick Cyr, André B. Charette

Abstract

A fundamentally simple, mild, and practical procedure for peptide bond formation is reported that employs a stoichiometric amount of easy-to-access 9-silafluorenyl dichlorides as the coupling agent. Without initial preactivation or elaboration of the carboxylic acid or amine termini of the amino acids, the developed reagent is proposed to act through an unprecedented chemical ligation mechanism, bringing the two coupling partners together before being subsequently eliminated. The desired amides or peptide bonds are thus furnished in good yields and with low to no epimerization.

Thumbnail image of graphical abstract

A chemical ligation mechanism was proposed for amide bond formation with 9-silafluorenyl dichlorides as new coupling reagents. This approach enabled the synthesis of peptides in a simple and unprecedented manner without preactivation of either the carboxylic acid or amine termini of the amino acids.

04 Oct 13:05

VEGF- and VEGFR2-Targeted Liposomes for Cisplatin Delivery to Glioma Cells

by Sergey A. Shein, Ilya I. Kuznetsov, Tatiana O. Abakumova, Pavel S. Chelushkin, Pavel A. Melnikov, Anna A. Korchagina, Dmitry A. Bychkov, Irina F. Seregina, Mikhail A. Bolshov, Alexander V. Kabanov, Vladimir P. Chekhonin and Natalia V. Nukolova

TOC Graphic

Molecular Pharmaceutics
DOI: 10.1021/acs.molpharmaceut.6b00519
03 Oct 18:15

α-Helical coiled-coil peptide materials for biomedical applications

by Yaoying Wu, Joel H. Collier

Self-assembling coiled coils, which occur commonly in native proteins, have received significant interest for the design of new biomaterials-based medical therapies. Considerable effort over recent years has led to a detailed understanding of the self-assembly process of coiled coils, and a diverse collection of strategies have been developed for designing functional materials using this motif. The ability to engineer the interface between coiled coils allows one to achieve variously connected components, leading to precisely defined structures such as nanofibers, nanotubes, nanoparticles, networks, gels, and combinations of these. Currently these materials are being developed for a range of biotechnological and medical applications, including drug delivery systems for controlled release, targeted nanomaterials, ‘drug-free’ therapeutics, vaccine delivery systems, and others. WIREs Nanomed Nanobiotechnol 2017, 9:e1424. doi: 10.1002/wnan.1424

For further resources related to this article, please visit the WIREs website.

Thumbnail image of graphical abstract

Coiled coils are oligomerizing structures useful for designing nanomaterials such as particles, fibers, and networks within biomedical applications.

30 Sep 17:41

Unimolecular Micelles of Amphiphilic Cyclodextrin-Core Star-Like Copolymers with Covalent pH-Responsive Linkage of Anticancer Prodrugs

by Tao Jia, Shuo Huang, Cangjie Yang and Mingfeng Wang

TOC Graphic

Molecular Pharmaceutics
DOI: 10.1021/acs.molpharmaceut.6b00708
23 Sep 17:59

Straightforward Glycoengineering Approach to Site-Specific Antibody–Pyrrolobenzodiazepine Conjugates

by Pamela Thompson, Ebele Ezeadi, Ian Hutchinson, Ryan Fleming, Binyam Bezabeh, Jia Lin, Shenlan Mao, Cui Chen, Luke Masterson, Haihong Zhong, Dorin Toader, Philip Howard, Herren Wu, Changshou Gao and Nazzareno Dimasi

TOC Graphic

ACS Medicinal Chemistry Letters
DOI: 10.1021/acsmedchemlett.6b00278
21 Sep 18:41

Interfering with the Dimerization of the ErbB Receptors by Transmembrane Domain-Derived Peptides Inhibits Tumorigenic Growth in Vitro and in Vivo

by Erez M. Bublil, Tomer Cohen, Christopher J. Arnusch, Adi Peleg, Gur Pines, Sara Lavi, Yosef Yarden and Yechiel Shai

TOC Graphic

Biochemistry
DOI: 10.1021/acs.biochem.6b00450
08 Sep 14:06

Membrane targeting and insertion of the C-tail protein SciP.

by Pross E, Soussoula L, Seitl I, Lupo D, Kuhn A

Membrane targeting and insertion of the C-tail protein SciP.

J Mol Biol. 2016 Sep 3;

Authors: Pross E, Soussoula L, Seitl I, Lupo D, Kuhn A

Abstract
C-tailed membrane proteins insert into the bilayer post-translationally because the hydrophobic anchor segment leaves the ribosome at the end of translation. Nevertheless, we find here evidence that the targeting of SciP to the membrane of Escherichia coli occurs co-translationally since signal elements in the N-terminal part of the SciP protein sequence are present. Two short hydrophobic sequences were identified that targeted a GFP-SciP fusion protein to the membrane involving the signal recognition particle (SRP). After targeting, the membrane insertion of SciP is catalysed by YidC independently of the SecYEG translocase. However, when the C-terminal tail of SciP was extended to 21 amino acid residues we found that SecYEG becomes involved and makes its membrane insertion more efficient.

PMID: 27600410 [PubMed - as supplied by publisher]

07 Sep 18:36

Covalent Targeting of FGFR Inhibits Metastasis

by Brown, W. S., Tan, L., Smith, A., Gray, N. S., Wendt, M. K.

Therapeutic targeting of late-stage breast cancer is limited by an inadequate understanding of how tumor cell signaling evolves during metastatic progression and by the currently available small molecule inhibitors capable of targeting these processes. Herein, we demonstrate that both β3 integrin and fibroblast growth factor receptor-1 (FGFR1) are part of an epithelial–mesenchymal transition (EMT) program that is required to facilitate metastatic outgrowth in response to fibroblast growth factor-2 (FGF2). Mechanistically, β3 integrin physically disrupts an interaction between FGFR1 and E-cadherin, leading to a dramatic redistribution of FGFR1 subcellular localization, enhanced FGF2 signaling and increased three-dimensional (3D) outgrowth of metastatic breast cancer cells. This ability of β3 integrin to drive FGFR signaling requires the enzymatic activity of focal adhesion kinase (FAK). Consistent with these mechanistic data, we demonstrate that FGFR, β3 integrin, and FAK constitute a molecular signature capable of predicting decreased survival of patients with the basal-like subtype of breast cancer. Importantly, covalent targeting of a conserved cysteine in the P-loop of FGFR1–4 with our newly developed small molecule, FIIN-4, more effectively blocks 3D metastatic outgrowth as compared with currently available FGFR inhibitors. In vivo application of FIIN-4 potently inhibited the growth of metastatic, patient-derived breast cancer xenografts and murine-derived metastases growing within the pulmonary microenvironment. Overall, the current studies demonstrate that FGFR1 works in concert with other EMT effector molecules to drive aberrant downstream signaling, and that these events can be effectively targeted using our novel therapeutics for the treatment of the most aggressive forms of breast cancer. Mol Cancer Ther; 15(9); 2096–106. ©2016 AACR.

07 Sep 18:35

Pathogenic cysteine removal mutations in FGFR extracellular domains stabilize receptor dimers and perturb the TM dimer structure.

by Sarabipour S, Hristova K

Pathogenic cysteine removal mutations in FGFR extracellular domains stabilize receptor dimers and perturb the TM dimer structure.

J Mol Biol. 2016 Sep 2;

Authors: Sarabipour S, Hristova K

Abstract
Missense mutations which introduce or remove cysteine residues in receptor tyrosine kinases (RTKs) are believed to cause pathologies by stabilizing the active RTK dimers. However, the magnitude of this stabilizing effect has not been measured for full-length receptors. Here, we characterize the dimer stabilities of three full-length fibroblast growth factor (FGFR) mutants harboring pathogenic cysteine substitutions: the C178S FGFR1 mutant, the C342R FGFR2 mutant, and the C228R FGFR3 mutant. We find that the three mutations stabilize the FGFR dimers. We further see that the mutations alter the configuration of the FGFR transmembrane (TM) dimers. Thus, both aberrant dimerization and perturbed dimer structure likely contribute to the pathological phenotypes arising due to these mutations.

PMID: 27596331 [PubMed - as supplied by publisher]

01 Sep 18:13

Nobel Laureate Roger Tsien dies at 64

by Elizabeth K. Wilson
Biochemist advanced the use of green fluorescent protein as a ubiquitous biological marker
01 Sep 15:14

DEP-1 Promotes Angiogenesis, Permeability, and Metastasis

by Fournier, P., Dussault, S., Fusco, A., Rivard, A., Royal, I.
The protein tyrosine phosphatase PTPRJ/DEP-1 has been implicated in negative growth regulation in endothelial cells, where its expression varies at transitions between proliferation and contact inhibition. However, in the same cells, DEP-1 has also been implicated in VEGF-dependent Src activation, permeability, and capillary formation, suggesting a positive role in regulating these functions. To resolve this dichotomy in vivo, we investigated postnatal angiogenesis and vascular permeability in a DEP-1–deficient mouse. In this study, we report that DEP-1 is required for Src activation and phosphorylation of its endothelial cell–specific substrate, VE-cadherin, after systemic injection of VEGF. Accordingly, VEGF-induced vascular leakage was abrogated in the DEP-1–deficient mice. Furthermore, capillary formation was impaired in murine aortic tissue rings or Matrigel plugs infused with VEGF. In the absence of DEP-1, angiogenesis triggered by ischemia or during tumor formation was defective, which in the latter case was associated with reduced tumor cell proliferation and increased apoptosis. Macrophage infiltration was also impaired, reflecting reduced vascular permeability in the tumors or a possible cell autonomous effect of DEP-1. Consequently, the formation of spontaneous and experimental lung metastases was strongly decreased in DEP-1–deficient mice. In clinical specimens of cancer, less vascularized tumors exhibited lower microvascular expression of DEP-1. Altogether, our results established DEP-1 as an essential driver of VEGF-dependent permeability, angiogenesis, and metastasis, suggesting a novel therapeutic route to cancer treatment. Cancer Res; 76(17); 5080–91. ©2016 AACR.
30 Aug 13:43

Antagonizing the Androgen Receptor with a Biomimetic Acyltransferase

by Yuchen Zhang, Pavan K. Mantravadi, Soma Jobbagy, Wei Bao and John T. Koh

TOC Graphic

ACS Chemical Biology
DOI: 10.1021/acschembio.6b00659
29 Aug 17:48

Linker Immolation Determines Cell Killing Activity of Disulfide-Linked Pyrrolobenzodiazepine Antibody–Drug Conjugates

by Donglu Zhang, Thomas H. Pillow, Yong Ma, Josefa dela Cruz-Chuh, Katherine R. Kozak, Jack D. Sadowsky, Gail D. Lewis Phillips, Jun Guo, Martine Darwish, Peter Fan, Jingtian Chen, Changrong He, Tao Wang, Hui Yao, Zijin Xu, Jinhua Chen, John Wai, Zhonghua Pei, Cornelis E. C. A. Hop, S. Cyrus Khojasteh and Peter S. Dragovich

TOC Graphic

ACS Medicinal Chemistry Letters
DOI: 10.1021/acsmedchemlett.6b00233
29 Aug 17:48

Enhancing Therapeutic Efficacy of Cisplatin by Blocking DNA Damage Repair

by Yuwei Cong, Liangyan Wang, Zigui Wang, Shasha He, Dongfang Zhou, Xiabin Jing and Yubin Huang

TOC Graphic

ACS Medicinal Chemistry Letters
DOI: 10.1021/acsmedchemlett.6b00236
26 Aug 14:01

Well-Defined Polymer–Paclitaxel Prodrugs by a Grafting-from-Drug Approach

by Benoit Louage, Lutz Nuhn, Martijn D. P. Risseeuw, Nane Vanparijs, Ruben De Coen, Izet Karalic, Serge Van Calenbergh, Bruno G. De Geest

Abstract

We report on the design of a polymeric prodrug of the anticancer agent paclitaxel (PTX) by a grafting-from-drug approach. A chain transfer agent for reversible addition fragmentation chain transfer (RAFT) polymerization was efficiently and regioselectively linked to the C2′ position of paclitaxel, which is crucial for its bioactivity. Subsequent RAFT polymerization of a hydrophilic monomer yielded well-defined paclitaxel–polymer conjugates with high drug loading, water solubility, and stability. The versatility of this approach was further demonstrated by ω-end post-functionalization with a fluorescent tracer. In vitro experiments showed that these conjugates are readily taken up into endosomes where native PTX is efficiently cleaved off and then reaches its subcellular target. This was confirmed by the cytotoxicity profile of the conjugate, which matches those of commercial PTX formulations based on mere physical encapsulation.

Thumbnail image of graphical abstract

Visible effects: Well-defined paclitaxel–polymer conjugates with high drug loading, water solubility, and stability were obtained by a grafting-from approach. They are readily taken up into endosomes where native paclitaxel is efficiently released. The versatility of this approach was further demonstrated by post-functionalization with a fluorescent tracer.

25 Aug 14:15

Overexpression of Antimicrobial, Anticancer, and Transmembrane Peptides in Escherichia coli through a Calmodulin-Peptide Fusion System

by Hiroaki Ishida, Leonard T. Nguyen, Ramamourthy Gopal, Tomoyasu Aizawa and Hans J. Vogel

TOC Graphic

Journal of the American Chemical Society
DOI: 10.1021/jacs.6b06781
22 Aug 14:50

Virus-Inspired Polymer for Efficient In Vitro and In Vivo Gene Delivery

by Yilong Cheng, Roma C. Yumul, Suzie H. Pun

Abstract

Clinical translation of nucleic acids drugs has been stunted by limited delivery options. Herein, we report a synthetic polymer designed to mimic viral mechanisms of delivery called VIPER (virus-inspired polymer for endosomal release). VIPER is composed of a polycation block for condensation of nucleic acids, and a pH-sensitive block for acid-triggered display of a lytic peptide to promote trafficking to the cell cytosol. VIPER shows superior efficiencies compared to commercial agents when delivering genes to multiple immortalized cell lines. Importantly, in murine models, VIPER facilitates effective gene transfer to solid tumors.

Thumbnail image of graphical abstract

A virus-inspired polymer is reported as an effective gene transfer vehicle. The polymer, called VIPER (virus-inspired polymer for endosomal release), is composed of a polycation block for nucleic acids condensation and a pH-sensitive block for acid-triggered display of a lytic peptide to promote trafficking to the cell cytosol both in vitro and in vivo.

22 Aug 13:45

PPII Helical Peptidomimetics Templated by Cation–π Interactions

by Timothy W. Craven, Richard Bonneau, Kent Kirshenbaum

Abstract

Poly-proline type II (PPII) helical PXXP motifs are the recognition elements for a variety of protein–protein interactions that are critical for cellular signaling. Despite development of protocols for locking peptides into α-helical and β-strand conformations, there remains a lack of analogous methods for generating mimics of PPII helical structures. We describe herein a strategy to enforce PPII helical secondary structure in the 19-residue TrpPlexus miniature protein. Through sequence variation, we showed that a network of cation–π interactions could drive the formation of PPII helical conformations for both peptide and N-substituted glycine peptoid residues. The achievement of chemically diverse PPII helical scaffolds provides a new route towards discovering peptidomimetic inhibitors of protein–protein interactions mediated by PXXP motifs.

Thumbnail image of graphical abstract

PPII helices on lockdown: A network of cation–π interactions was used to template peptide and peptoid residues into left-handed poly-proline type II (PPII) helices, covalently locking the secondary structure with an engineered disulfide bridge. These chemically diverse PPII helical structures provide a new route toward peptidomimetic protein–protein interaction inhibitors.

22 Aug 13:45

The Added Value of Assessing Ligand–Receptor Binding Kinetics in Drug Discovery

by Dong Guo, Laura H. Heitman and Adriaan P. IJzerman

TOC Graphic

ACS Medicinal Chemistry Letters
DOI: 10.1021/acsmedchemlett.6b00273
19 Aug 17:59

Blurring the Role of Oligonucleotides: Spherical Nucleic Acids as a Drug Delivery Vehicle

by Xuyu Tan, Xueguang Lu, Fei Jia, Xiaofan Liu, Yehui Sun, Jessica K. Logan and Ke Zhang

TOC Graphic

Journal of the American Chemical Society
DOI: 10.1021/jacs.6b07554